Toceranib is a small-molecule tyrosine kinase inhibitor primarily used as an antineoplastic agent for the treatment of mast cell tumors in dogs, with potential applications for various carcinomas, sarcomas,… Read more
Toceranib is a small-molecule tyrosine kinase inhibitor primarily used as an antineoplastic agent for the treatment of mast cell tumors in dogs, with potential applications for various carcinomas, sarcomas, and melanomas in veterinary oncology. Analytical laboratories rely on high-quality reference standards of Toceranib and its related compounds for critical tasks such as impurity profiling, method development, and quality control. This collection includes the active pharmaceutical ingredient along with essential materials for rigorous validation processes, including identified degradation products like N-oxide, synthetic impurities such as N-nitroso derivatives, and stable isotope labelled compounds. These specialized standards are indispensable for quantitative analysis, enabling chemists to accurately identify, monitor, and quantify trace impurities in drug substance batches, ensuring compliance with regulatory guidelines and maintaining the consistency of pharmacological research and drug manufacturing protocols.